Why are you using an aromatase inhibitor drug in this study?
ER+ breast cancers rely on oestrogen to grow and survive. Taking endocrine therapy with an aromatase inhibitor stops the body making oestrogen.
This starves the tumour of this hormone. This is why endocrine therapy with an aromatase inhibitor is very effective at both treating and preventing ER+ breast cancer.
It can also help ER+ breast cancers to shrink by stopping the ‘fuel’ that ER+ breast cancers use to grow. This is why we are using it in this study.